NCT02067806View on ClinicalTrials.gov

Observational Study on 2-chloroprocaine Hydrochloride 1%

CompletedOBSERVATIONAL

Enrollment

394

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions

Neurological Complication, in Particular TNS or CES

Interventions

DRUG

2-chloroprocaine hydrochloride, 1%

Study included male and female adult patients undergoing spinal anesthesia with chloroprocaine, when the planned surgical procedure was not expected to exceeded 40 minutes.

Trial Locations (1)

2390

Department of Anesthesiology and Critical Care Medicine-Hospital AZ Sint Jozef, Malle

All Listed Sponsors

collaborator

Sintesi Research Srl

INDUSTRY

lead

Sintetica SA

INDUSTRY

NCT02067806 - Observational Study on 2-chloroprocaine Hydrochloride 1% | Biotech Hunter | Biotech Hunter